Welcome to eviQ
A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.
Find out more
A NEW template has been developed allowing for a single protocol with multiple indications. The first example is metastatic nivolumab for melanoma, NSCLC and RCC to be published on Tues 5th Feb 2019. Read the attached PDF for more information.
New eviQ Education module.
This course presents information about the epidemiology, clinical manifestations and management principles of adult fever and neutropenia.
Following the 1st August 2018 expanded PBS listing for pegfilgrastim to include primary prophylaxis for patients with >20% risk of FN, eviQ is reviewing all impacted protocols. Further information of protocol updates will follow.
See eviQ's Program Director Professor Robyn Ward talk about how and why eviQ was developed, its purpose and the governance processes that ensure its high quality content.